Nov
DEC
Jan
21
2014
2015
2016
1 captures
21 Dec 15 - 21 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Thrombotic Disorders
The Physiologic Time Window in Acute Stroke
Phase 2 Trial Provides Safety and Outcomes Data on Novel Anticoagulant Agent
Tailored Clopidogrel Dosing Reduces Adverse Events in Patients with Clopidogrel Resistance Undergoing PCI
Home Anticoagulation Monitoring is Safe for Patients with Atrial Fibrillation or Mechanical Heart Valves
Acute Coronary Syndrome: Year in Review
Promise and Problems Emerge for Oral Investigative Factor Xa Drug in Treating Acute Coronary Syndrome
Stroke Prevention in Atrial Fibrillation
Key Updates to the UA/NSTEMI and STEMI Guidelines
Bivalirudin Not Superior to Unfractionated Heparin in Patients Receiving 600 mg Clopidogrel Prior to PCI
Advantage of Prasugrel over Clopidogrel Holds across Range of Patient- and Procedure-Related Factors
Pages
Previous
Next
1
…
6
7
8
9
10
11
12
13
14